key topics
navigation
|
What About Accreditation For
PA Postgraduate Programs?
| | |
All physician assistant (PA) education programs stress primary care as a fundamental core of knowledge and only graduates of accredited PA programs are eligible to sit for the PA National Certification Examination (PANCE). The PANCE and the recertification examination have more of a primary care focus and specialty examinations are not available. Accordingly, the rheumatology PA needs to be skilled in primary care to recertify.
The vast majority of PAs working in clinical specialties have learned their skills through on-the-job experience and not through a PA postgraduate program. Physician assistants remain fully capable of entering specialty practices based on previous experiences and training. Maintaining this clinical flexibility is a valued cornerstone of the profession, one that continues to attract talented individuals into the field.
However, an issue in PA education that surfaces in policy debates is the importance of accreditation of postgraduate educational programs and the certification of its graduates. Physician assistant postgraduate programs have been part of the profession since 1972. The prototypical PA postgraduate program, also referred to as a PA residency, is a one-year, hospital-based clinical training experience in a specialty field. As postgraduate programs have grown in number and popularity over the years, the development of some form of accreditation system for these programs has emerged.
In 2006, the Accreditation Review Commission for the Physician Assistant (ARC-PA) announced it will institute a voluntary process to accredit PA postgraduate programs. What are the potential implications for the PA profession?
By providing an accreditation process, the ARC-PA will establish professionally developed standards for such programs. This is important as the focus and quality of postgraduate programs has been uneven. Under this new process, accreditation status will offer important information to the prospective PA seeking advanced training. In other words, the program will have a defined educational focus and not one that is strictly service-driven in its orientation.
One argument is that accreditation will confer legitimacy on PA postgraduate programs, allowing those that provide quality clinical education to become more firmly established and better recognized. Others believe it is in society’s best interest to have a legitimate body overseeing the quality of PA postgraduate education. However, this action has troubled many PA constituents who feel that the primary care roots of the profession will be devalued.
While rheumatology has been a specialty for PAs since 1978, there has only been a formal rheumatology postgraduate PA program since 2003. Like all other postgraduate programs for PAs, the postgraduate PA program in rheumatology sponsored by the University of Texas is not accredited nor does it produce a standardized certificate of accomplishment.
The American Academy of Physician Assistants (AAPA) has expressed its concern regarding the accreditation of PA postgraduate programs. There is a fear that recognizing programs in this fashion may narrow the entry of PAs into various clinical fields unless they possess postgraduate training.
To date, there is no evidence that residency training is becoming a qualification for either employment in a particular clinical specialty or for entry into practice. There is also no evidence that this education has much of an impact. The number of graduates of the 30 or so postgraduate programs is less than 80 a year, less than 1 percent of the total number of annual graduates of all postgraduate programs in the U.S. (almost 5,000 in 2005).
For example, if one looks at cardiothoracic PAs, there is no formal evidence or even anecdotal reports that fellowship trained PAs do better in their specialty in terms of salary or scope of function than PAs who are trained on the job. Even if the numbers of postgraduate PAs would quadruple over the next five years, the impact is likely to be negligible on employer demand or in improving the supply of formally trained PAs in cardiovascular surgery or rheumatology.
In the end, accreditation is underway and the standards for programs will be set by the ARC-PA in a voluntary format. Since the training of PAs in a fellowship setting is expensive, programs may not proliferate to the degree that some expect in the next decade. In the meantime, there are opportunities to examine how these programs function and whether there is more value for those who obtain the advanced training.
|
|
| Arthritis Practitioner - ISSN: 1 - Volume 2 - Issue 6 - November 2006 - Pages: 40 - | |
|
A complimentary CME Webcast Event
To register for this Web Archive program, click on Complimentary CME Webcast Event
This activity is for nurse practitioners, physician assistants, rheumatologists and internal medicine
physicians who treat patients with rheumatoid arthritis (RA).
Panelists/Lectures
"What You Should Know About Treating Early RA"
Nathan Wei, MD
Clinical Director
Arthritis and
Osteoporosis Center
Frederick, Md.
"A Closer Look At The Efficacy And Safety Of Combination Therapy With Anti-TNF Agents"
Philip Mease, MD
Clinical Professor
University of Washington
School of Medicine
Chief, Rheumatology Clinical Research
Swedish Hospital Medical Center
Seattle
"What The Studies Reveal About Emerging Therapies For RA"
Salahuddin Kazi, MD
Chief of Rheumatology
Presbyterian Hospital
Dallas,Tx.
This activity is supported by an educational grant from Genentech and Biogen Idec. The activity is sponsored by the North American Center for Continuing Medical Education (NACCME).
A complimentary CME Webcast Event
ON DEMAND
(Q&A with panelists to follow lectures)
To register for this Webcast program, click on Complimentary CME Webcast
This activity is geared to physicians, rheumatologists, nurses, physician assistants and nurse practitioners who treat rheumatoid arthritis.
Agenda And Faculty
“Treating RA: The Shift To A More Aggressive Therapeutic Approach”
Linda Davis, MHS, PA-C
Assistant Professor
University Of North Texas Health Science Center
“What The Literature Reveals About Combination Therapy”
Kevin M. Latinis, MD, PhD
Division of Allergy, Clinical Immunology and Rheumatology
University of Kansas Medical Center
“New Biologic DMARDs: Can They Have An Impact?”
Salahuddin Kazi, MD
Chief of Rheumatology
Presbyterian Hospital
Dallas, Texas
This activity is supported by an educational grant from Bristol-Myers Squibb. The activity is sponsored by the North American Center for Continuing Medical Education (NACCME).
A complimentary CME Web Archive Event
To register for this Web Archive program, click on Complimentary CME Web Archive Event
This activity is geared to physicians, nurses, physician assistants and nurse practitioners who treat osteoarthritis.
Agenda And Faculty
“A Closer Look At The Role Of Intraarticular Injections”
Frank Caruso, PA-C
Physician Assistant
Wake Forest University Baptist Medical Center
Winston-Salem, NC
“What The Literature Reveals About Viscosupplementation”
Nathan Wei, MD
Clinical Director
Arthritis and Osteoporosis Center
Frederick, MD
“Mastering The Technique Of Intraarticular Injections”
Mike Rudzinski, PA-C
Physician Assistant
Buffalo Veterans Affairs Medical Center
Buffalo, NY
This activity is supported by an educational grant from Genzyme. The activity is sponsored by the North American Center for Continuing Medical Education (NACCME).
A Complimentary CME Webcast Event
A Complimentary, On-Demand CME Webcast
To register for this Webcast program, click on Complimentary CME Webcast Event
This activity is geared to physicians, nurses, physician assistants and nurse practitioners who treat rheumatoid arthritis.
AGENDA and FACULTY
"Reviewing The Role of DMARDs In Treating RA"
Don Flinn, PA-C
Physician Assistant, McBride Clinic, Oklahoma City, Ok.
Vice-President, Society Of Physician Assistants In Rheumatology
"Assessing The Potential of Biologic Therapies"
Mark Genovese, MD
Associate Professor of Medicine
Division of Immunology And Rheumatology
Stanford University School Of Medicine
"What You Should Know About Infusion Therapy"
Nathan Wei, MD
Clinical Director
Arthritis and Osteoporosis Center
Frederick, Md.
This activity is supported by an educational grant from Bristol-Myers Squibb.
The activity is sponsored by the North American Center for Continuing Medical Education (NACCME).
Educational Monographs

In a CME/CE roundtable discussion, expert panelists review the subtypes of JIA, keys to patient adherence and insights on treatments ranging from NSAIDs and methotrexate to emerging biologic agents.
This CME monograph is supported by an educational grant from Abbott Laboratories. It is sponsored by the North American Center for Continuing Medical Education (NACCME).
|